|
College of American Pathologists
breast biomarkers Breast Biomarkers, supplied by College of American Pathologists, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/er+pr+her+2+positive+breast+cancer+cell+line+mcf/breast+biomarker+reporting+guidelines/pmc07073136-252-1-24 Average 90 stars, based on 1 article reviews
breast biomarkers - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
Abcam
primary antibody incubation Primary Antibody Incubation, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/er+pr+her+2+positive+breast+cancer+cell+line+mcf/Anti-ErbB2+%2F+HER2+antibody/pmc05762303-271-14-19 Average 99 stars, based on 1 article reviews
primary antibody incubation - by Bioz Stars,
2026-10
99/100 stars
|
Buy from Supplier |
|
ATCC
triple negative breast cancer mdamb231 cell line Triple Negative Breast Cancer Mdamb231 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/er+pr+her+2+positive+breast+cancer+cell+line+mcf/MDA-MB-231/pm27793938-63-0-6 Average 99 stars, based on 1 article reviews
triple negative breast cancer mdamb231 cell line - by Bioz Stars,
2026-10
99/100 stars
|
Buy from Supplier |
|
NanoCarrier Co
pluronic ® f127 ![]() Pluronic ® F127, supplied by NanoCarrier Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/er+pr+her+2+positive+breast+cancer+cell+line+mcf/pluronic+f127/pmc09139219-348-23-26 Average 90 stars, based on 1 article reviews
pluronic ® f127 - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
Dow Corning
bacteria against drugresistant triple negative breast cancer tnbc model ![]() Bacteria Against Drugresistant Triple Negative Breast Cancer Tnbc Model, supplied by Dow Corning, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/er+pr+her+2+positive+breast+cancer+cell+line+mcf/against+bacteria+breast+cancer+drugresistant+model+negative+tnbc+triple/pm41260901-101-5-20 Average 86 stars, based on 1 article reviews
bacteria against drugresistant triple negative breast cancer tnbc model - by Bioz Stars,
2026-10
86/100 stars
|
Buy from Supplier |
|
ATCC
non triple negative breast cancer nontnbc cell line mcf ![]() Non Triple Negative Breast Cancer Nontnbc Cell Line Mcf, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/er+pr+her+2+positive+breast+cancer+cell+line+mcf/MCF7/pm41866545-59-22-32 Average 99 stars, based on 1 article reviews
non triple negative breast cancer nontnbc cell line mcf - by Bioz Stars,
2026-10
99/100 stars
|
Buy from Supplier |
|
ATCC
human er pr her2 ![]() Human Er Pr Her2, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/er+pr+her+2+positive+breast+cancer+cell+line+mcf/SK-BR-3/pmc04571892-78-0-18 Average 97 stars, based on 1 article reviews
human er pr her2 - by Bioz Stars,
2026-10
97/100 stars
|
Buy from Supplier |
|
ATCC
murine triple negative breast cancer 4t1 cell lines ![]() Murine Triple Negative Breast Cancer 4t1 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/er+pr+her+2+positive+breast+cancer+cell+line+mcf/4T1/pm39742392-257-5-17 Average 99 stars, based on 1 article reviews
murine triple negative breast cancer 4t1 cell lines - by Bioz Stars,
2026-10
99/100 stars
|
Buy from Supplier |
|
ATCC
tumour cell lines hcc1806 ![]() Tumour Cell Lines Hcc1806, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/er+pr+her+2+positive+breast+cancer+cell+line+mcf/HCC1806/pm39914031-124-1-31 Average 97 stars, based on 1 article reviews
tumour cell lines hcc1806 - by Bioz Stars,
2026-10
97/100 stars
|
Buy from Supplier |
|
ATCC
hs 578t triple negative breast cancer cell lines ![]() Hs 578t Triple Negative Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/er+pr+her+2+positive+breast+cancer+cell+line+mcf/Hs+578T/pmc10172997-70-3-14 Average 97 stars, based on 1 article reviews
hs 578t triple negative breast cancer cell lines - by Bioz Stars,
2026-10
97/100 stars
|
Buy from Supplier |
|
DSMZ
jimt 1 cells ![]() Jimt 1 Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/er+pr+her+2+positive+breast+cancer+cell+line+mcf/JIMT-1/pmc12617690-146-0-16 Average 96 stars, based on 1 article reviews
jimt 1 cells - by Bioz Stars,
2026-10
96/100 stars
|
Buy from Supplier |
|
ATCC
triple positive bt474 ![]() Triple Positive Bt474, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/er+pr+her+2+positive+breast+cancer+cell+line+mcf/BT-474%3B+Breast+Ductal+Carcinoma%3B+Human/pmc07360846-60-15-24 Average 96 stars, based on 1 article reviews
triple positive bt474 - by Bioz Stars,
2026-10
96/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cancers
Article Title: Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy
doi: 10.3390/cancers14102473
Figure Lengend Snippet: Examples of nanoparticles responsive to biochemical features of the tumor microenvironment.
Article Snippet: Testing the derived nanoparticles revealed the optimal performance of diselenide bond-including paclitaxel dimers (in terms of response to reductive conditions) included in the
Techniques: Starch
Journal: Cancers
Article Title: Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy
doi: 10.3390/cancers14102473
Figure Lengend Snippet: Examples of antibody fragment-functionalized nanoparticles for targeted drug delivery.
Article Snippet: Testing the derived nanoparticles revealed the optimal performance of diselenide bond-including paclitaxel dimers (in terms of response to reductive conditions) included in the
Techniques: In Vitro, In Vivo
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Article Title: Nitric Oxide-Releasing Nanoscale Metal-Organic Layer Overcomes Hypoxia and Reactive Oxygen Species Diffusion Barriers to Enhance Cancer Radiotherapy.
doi: 10.1002/advs.202413518
Figure Lengend Snippet: Figure 4. In vitro anticancer effect of SNAP/MOL under X-ray irradiation. a) Cellular uptake of MOL and SNAP/MOL determined by ICP-MS. b) Clono- genic assays to evaluate radioenhancement of MOL and SNAP/MOL in 4T1 cells. n = 3. c) Quantitation of cell apoptosis and necrosis after different treatments. n = 3. d) Representative flow cytometry results showing cell apoptosis and necrosis co-stained with Annexin-V and PI. e) CLSM images, f) western blot results, and g) flow cytometry analysis of 𝛾-H2AX signals after different treatments. All data are shown as mean±SD.
Article Snippet: Murine colorectal carcinoma CT26 and
Techniques: In Vitro, Irradiation, Quantitation Assay, Cytometry, Staining, Western Blot
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Article Title: Nitric Oxide-Releasing Nanoscale Metal-Organic Layer Overcomes Hypoxia and Reactive Oxygen Species Diffusion Barriers to Enhance Cancer Radiotherapy.
doi: 10.1002/advs.202413518
Figure Lengend Snippet: Figure 5. Mechanistic studies of radiosensitization of SNAP/MOL. CLSM images showing distribution of a) ONOO−and b) ROS in 4T1 cells after SNAP/MOL(+) treatment. c) Colocalization between nucleus (blue) and ONOO−(red) in the region of interest (ROI, white arrow in Figure 5a). d) Colocalization between nucleus (blue) and ROS (green) in the ROI (white arrow in Figure 5b). e) Relative nucleus distribution (RND) statistics for ONOO−and ROS. n = 10. f) Flow cytometry results showing the hypoxia level of 4T1 cells after different treatments. g) Intracellular ATP levels of 4T1 cells after different treatments. f,g, data are presented as mean ± SD (n = 3). Statistical significance was calculated via unpaired two-tailed student’s t test. *p<0.05, ***p<0.001.
Article Snippet: Murine colorectal carcinoma CT26 and
Techniques: Flow Cytometry, Two Tailed Test
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Article Title: Nitric Oxide-Releasing Nanoscale Metal-Organic Layer Overcomes Hypoxia and Reactive Oxygen Species Diffusion Barriers to Enhance Cancer Radiotherapy.
doi: 10.1002/advs.202413518
Figure Lengend Snippet: Figure 6. In vivo antitumor effects. a) Tumor growth profiles of CT26-tumor-bearing mice after different treatments. b) Resected CT26 tumor weights on day 21. c) Tumor growth profiles of 4T1-tumor-bearing mice with various treatment regimens. d) Resected tumor weights of 4T1 tumor-bearing BALB/c mice at the end of therapies. e) TUNEL, g) H&E and h) 𝛾-H2AX staining of excised 4T1 tumors. Scale bars, 50 μm. Quantification of positive cell percentage in IHC staining of f) TUNEL and i) 𝛾-H2AX for evaluation of DNA damage and apoptosis. All data are shown as mean±SD, n = 5. Statistical significance was calculated via unpaired two-tailed student’s t test. *p<0.05, **p< 0.01, ***p<0.001.
Article Snippet: Murine colorectal carcinoma CT26 and
Techniques: In Vivo, TUNEL Assay, Staining, Immunohistochemistry, Two Tailed Test
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Article Title: Nitric Oxide-Releasing Nanoscale Metal-Organic Layer Overcomes Hypoxia and Reactive Oxygen Species Diffusion Barriers to Enhance Cancer Radiotherapy.
doi: 10.1002/advs.202413518
Figure Lengend Snippet: Figure 7. Pulmonary metastasis assessment and mechanistic summary. a) Representative images of H&E staining of lungs of 4T1-tumor-bearing BALB/c mice after different treatments. b) Statistical analysis of pulmonary metastatic nodules in different groups. n = 4. c) NO level in tumor tissues mea- sured by CLSM using probe DAF-FM. d) Representative IHC staining of HIF-1𝛼(brown) in excised 4T1 tumors after different treatments. Scale bars, 50 μm. e) Quantification of HIF-1𝛼positive cells by IHC staining to assess tumor hypoxia. n = 5. f) Schematic presentation of SNAP/MOL-mediated radiosensitization. Under low-dose X-ray irradiation, SNAP/MOL releases NO and ROS in a spatiotemporally synchronized manner, leading to efficient generation of long-lived and highly toxic ONOO−, thereby increasing DNA damage. Meanwhile, the sustained release of NO in the TME relieves tumor hypoxia and reduces radioresistance of tumor cells. Figure 7f was created with BioRender.com. All data are shown as mean±SD. Statistical significance was calculated via unpaired two-tailed student’s t test. *p<0.05.
Article Snippet: Murine colorectal carcinoma CT26 and
Techniques: Staining, Immunohistochemistry, Irradiation, Two Tailed Test
Journal: Bioorganic chemistry
Article Title: Novel steroidal oximes as antiproliferative agents: Design, synthesis and biological activity evaluation.
doi: 10.1016/j.bioorg.2025.108229
Figure Lengend Snippet: Fig. 2. Influence of OX1 and EP2OX on the H1299, PC3 and HCC1806 cells distribution by the different phases of the cell cycle. The cells were treated for 48 h with two different concentrations: one corresponding to the IC50 of each compound in each cell line and the other superior to the IC50 – 50 µM for OX1 and 15 µM for EP2OX. Results of the cell cycle express the percentage of cells in Sub-G1, G0/G1 phase, S phase and G2/M phase and represent the mean ± SD of four independent experiments. Significant differences are denoted by *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.
Article Snippet: The
Techniques:
Journal: Bioorganic chemistry
Article Title: Novel steroidal oximes as antiproliferative agents: Design, synthesis and biological activity evaluation.
doi: 10.1016/j.bioorg.2025.108229
Figure Lengend Snippet: Fig. 3. Viability and cell death profile induced by OX1 and EP2OX in H1299, PC3 and HCC1806 cancer cells. The cells were treated for 48 h with two different concentrations: one corresponding to the IC50 of each compound in each cell line and the other superior to the IC50 – 50 µM for OX1 and 15 µM for EP2OX. Results are presented as a percentage (%) of viable cells (V), in early apoptosis (A), in late apoptosis/necrosis (A/N) and necrosis (N) and express the mean ± SD of, at least, four independent experiments. Significant differences are denoted by *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.
Article Snippet: The
Techniques:
Journal: Bioorganic chemistry
Article Title: Novel steroidal oximes as antiproliferative agents: Design, synthesis and biological activity evaluation.
doi: 10.1016/j.bioorg.2025.108229
Figure Lengend Snippet: Fig. 6. DNA damage assessment induced by EP2OX in H1299, PC3 and HCC1806 cancer cells. A – Levels of γH2AX, 48 h after treatment with EP2OX, at two different concentrations: one corresponding to the IC50 of each cell line and the other higher than the IC50 (15 µM). Expression levels are presented normalized to control (dashed line). Results express the mean ± SD of, at least, four independent experiments. B – DNA damage in H1299 cancer cells using halo assay, 48 h after treatment with EP2OX at two different concentrations: 1.13 and 2.50 µM. Representative images of non-treated cells; positive control: cells treated with H2O2 at 400 µM; cells treated with EP2OX at 1.13 µM; cells treated with EP2OX at 2.50 µM. Halo images were analyzed using HaloJ plugin in ImageJ. Bar: 20 µm. Magnification: 20Х. C – Percentage of DNA in halo nuclei and NDF. Results present the median of three independent experiments, obtained by quantifying 75–120 images using the HaloJ program. Significant differences are denoted by *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001 for both experiments.
Article Snippet: The
Techniques: Expressing, Control, Halo Assay, Positive Control
Journal: Macromolecular Bioscience
Article Title: Evaluation of HER2 Targeted Poly(Ethylene Glycol)‐Poly( L ‐histidine) Copolymer Micelles in Breast Cancer Models
doi: 10.1002/mabi.202500047
Figure Lengend Snippet: Cellular association of PEG‐PHis‐RB micelle variants after 3 or 24 h incubation. Cells were incubated at 37°C with PEG‐PHis‐RB micelles with or without TZM conjugation either for 3 or 24 h, respectively. Cells were harvested and analyzed by flow cytometry. 5000—10 000 events were collected per sample. Mean fluorescence intensity (MFI) with respect to RB for (A) SKBR3 cells and (B) JIMT1 cells is presented here as % of untreated control ± SEM of 2 or 3 independent experiments, each performed with either duplicates or triplicates. Data are analyzed by multiple t‐ tests for 3 h, and two‐way ANOVA for 24 h. * p < 0.05, ** p < 0.01, **** p < 0.0001.
Article Snippet:
Techniques: Incubation, Conjugation Assay, Flow Cytometry, Fluorescence, Control
Journal: Macromolecular Bioscience
Article Title: Evaluation of HER2 Targeted Poly(Ethylene Glycol)‐Poly( L ‐histidine) Copolymer Micelles in Breast Cancer Models
doi: 10.1002/mabi.202500047
Figure Lengend Snippet: Effects of empty PEG‐His micelles with or without TZM conjugation on cell lines with varying HER2 expression levels. SKBR3 (HER2 high) or JIMT1 cells (HER2 moderate) were treated with empty PEG‐PHis micelle variants at a concentration equivalent to 4 µg/mL TZM. Untreated cells and treatment with free TZM were set as controls. (A) % cell confluence normalized to day 0 of treatment (B) Representation of the values 3 days after treatment, showing statistical significance. (C) MTT assay performed after 3 days with the same treatments. Values represent mean ± SD. Here, statistical analysis between control vs. TZM in SKBR3 cells has been performed by an unpaired t ‐test with Welch correction. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Article Snippet:
Techniques: Conjugation Assay, Expressing, Concentration Assay, MTT Assay, Control
Journal: Frontiers in Immunology
Article Title: Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells
doi: 10.3389/fimmu.2020.01171
Figure Lengend Snippet: Flow cytometric analysis of apoptosis induction in breast cancer cells treated with 20 μg/ml of immobilized and solution-phase rfhSP-D for 24 h.
Article Snippet: Human breast cancer cell lines, triple-negative BT20 (ER − /PR − /HER2 − ) (ATCC-HTB19),
Techniques:
Journal: Frontiers in Immunology
Article Title: Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells
doi: 10.3389/fimmu.2020.01171
Figure Lengend Snippet: Apoptosis induction in BT20, BT474, and SKBR3 cell lines following HA challenge in the presence and absence of rfhSP-D (A) . The data were expressed as the mean of three independent experiments ( n = 3). A significant difference was seen among treated and untreated samples, as made evident by the shift in the fluorescence intensity. Staurosporine (1 μM/ml) was used as a positive control. Proliferative effects of rfhSP-D treatment on BT474 and SKBR3 breast cancer cell lines (B) . BT474 and SKBR3 cells were seeded in wells pre-coated with HA, HA + rfhSP-D, and rfhSP-D alone. The percentage of proliferative cells was evaluated by staining with mouse anti-human KI-67 antibody, and KI-67-stained cells were measured via flow cytometry. The data were generated from at least three independent experiments ( n = 3) and presented as mean ± SD (* p < 0.1, ** p < 0.01, and **** p < 0.0001). The statistical analysis was performed between rfhSP-D and HA + rfhSP-D-treated breast cancer cells. The secretion levels of FL-SP-D were confirmed and analyzed via western blotting (C) . Culture medium collected from BT20, BT474, and SKBR3 cell lines was passed through a maltose Agarose column, and the eluted fractions were validated via western blotting; FL-SP-D was detected at ~43 kDa only for BT474. Both BT20 and SKBR3 cell lines did not secrete any FL-SP-D. Secreted FL-SP-D by BT474 was tested for its ability to induce apoptosis (D) . No effect of secreted FL-SP-D was seen in terms of cell viability and apoptosis induction.
Article Snippet: Human breast cancer cell lines, triple-negative BT20 (ER − /PR − /HER2 − ) (ATCC-HTB19),
Techniques: Fluorescence, Positive Control, Staining, Flow Cytometry, Generated, Western Blot
Journal: Frontiers in Immunology
Article Title: Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells
doi: 10.3389/fimmu.2020.01171
Figure Lengend Snippet: Intracellular signaling to show phosphorylation of p53 in rfhSP-D-treated BT20 and SKBR3 cell lines (A) . Breast cancer cell lines were allowed to adhere to HA or HA-bound rfhSP-D, and the phosphorylation status of p53 was evaluated using total cell lysates with a PathScan Antibody Array Kit (Cell Signaling). Data were generated from at least three independent experiments and presented as mean ± SD. rfhSP-D treatment resulted in upregulation of p21 and p27 cell cycle inhibitors (B) . BT20, BT474, and SKBR3 (0.4 × 10 6 ) cells were seeded in a six-well-plate pre-coated with rfhSP-D and HA + rfhSP-D. The treated cells were lysed and pelleted down. The pelleted cells were subjected to RNA isolation, followed by cDNA synthesis and qPCR. The comparative quantification method was performed to calculate the efficiencies of each gene for each individual PCR and is based on the second differential maximum method or takeoff analysis. The takeoff results obtained with p21/p27 primers were normalized with the housekeeping gene TBP. qPCR assay was conducted in triplicates, and error bars represent ± SEM. Unpaired one-way ANOVA test was used to determine the significance; * p < 0.05, ** p < 0.01, and *** p < 0.001 ( n = 3). The statistical analysis was performed between rfhSP-D and HA + rfhSP-D-treated breast cancer cells.
Article Snippet: Human breast cancer cell lines, triple-negative BT20 (ER − /PR − /HER2 − ) (ATCC-HTB19),
Techniques: Phospho-proteomics, Ab Array, Generated, Isolation, cDNA Synthesis